Rockwell Medical (RMTI) Interest Expenses (2010 - 2026)
Rockwell Medical (RMTI) posted Interest Expenses of $5.8 million for Q1 2026, up 1084.39% on a QoQ basis from $487000.0 in Q4 2025, and up 944.93% year-over-year from $552000.0 in Q1 2025.
Rockwell Medical (RMTI) Interest Expenses (2010 - 2026) Analysis & Trends
Rockwell Medical's Interest Expenses history runs 17 years deep, the most recent figure standing at $5.8 million for Q1 2026.
- Quarterly Interest Expenses rose 944.93% year-over-year to $5.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (up 944.93% YoY) and the FY2025 annual result came in at $6.9 million, down 91.91% from the prior year.
- Interest Expenses was $5.8 million for Q1 2026 at Rockwell Medical, up from $487000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $5.8 million in Q1 2026 and bottomed at $289000.0 in Q4 2024.
- A 5-year average of $879470.6 and a median of $478000.0 in 2023 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2024 — Interest Expenses tumbled 78.94% — and 2026, when it soared 944.93%.
- Rockwell Medical's Interest Expenses stood at $439000.0 in 2022, then surged by 212.53% to $1.4 million in 2023, then tumbled by 78.94% to $289000.0 in 2024, then soared by 68.51% to $487000.0 in 2025, then jumped by 1084.39% to $5.8 million in 2026.
- Business Quant data shows RMTI's Interest Expenses at $5.8 million in Q1 2026, $487000.0 in Q4 2025, and $552000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.77 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 5.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.77 Mn |
| Mar 31, 2026 | 5.77 Mn |
| Dec 31, 2025 | 487,000.00 |
| Dec 31, 2025 | 487,000.00 |
| Sep 30, 2025 | 552,000.00 |
| Sep 30, 2025 | 552,000.00 |
| Jun 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 1.32 Mn |
| Mar 31, 2025 | 552,000.00 |
| Mar 31, 2025 | 552,000.00 |
| Dec 31, 2024 | 289,000.00 |
| Dec 31, 2024 | 289,000.00 |
| Sep 30, 2024 | 449,000.00 |
| Sep 30, 2024 | 449,000.00 |
| Jun 30, 2024 | 426,000.00 |
| Jun 30, 2024 | 426,000.00 |
| Mar 31, 2024 | 437,000.00 |
| Mar 31, 2024 | 437,000.00 |
| Dec 31, 2023 | 1.37 Mn |
| Dec 31, 2023 | 1.37 Mn |